These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 28072783)
1. After Theranos. Waltz E Nat Biotechnol; 2017 Jan; 35(1):11-15. PubMed ID: 28072783 [No Abstract] [Full Text] [Related]
2. Companion diagnostics: the next step in personalized clinical care. Thongkham D; Terry SF Genet Test Mol Biomarkers; 2012 Oct; 16(10):1155-6. PubMed ID: 23057592 [No Abstract] [Full Text] [Related]
3. Industrialized molecular biology, information biotechnology, and the blockbuster drug model--alive and well at age 50. Augen J Drug Discov Today; 2002 Oct; 7(20 Suppl):S157-9. PubMed ID: 12546898 [No Abstract] [Full Text] [Related]
4. Market opportunities and technology trends in point of care diagnostics - SMi conference. Shirvill J IDrugs; 2006 Apr; 9(4):263-5. PubMed ID: 16596479 [No Abstract] [Full Text] [Related]
5. Theranos: Almost Complete Absence of Laboratory Medicine Input. Fiala C; Diamandis EP J Appl Lab Med; 2019 Mar; 3(5):749-752. PubMed ID: 31639748 [No Abstract] [Full Text] [Related]
6. Biotech research: bringing better therapies to the people. Heinzelmann E Chimia (Aarau); 2010; 64(1-2):91-3. PubMed ID: 21137693 [TBL] [Abstract][Full Text] [Related]
7. Theranos phenomenon - part 4: Theranos at an International Conference. Diamandis EP Clin Chem Lab Med; 2016 Aug; 54(8):e243-4. PubMed ID: 27259230 [No Abstract] [Full Text] [Related]
8. The coming era of nanomedicine. Allhoff F Am J Bioeth; 2009 Oct; 9(10):3-11. PubMed ID: 19998074 [TBL] [Abstract][Full Text] [Related]
9. Companion diagnostics: emerging strategies and issues in pharmaceutical development. Thomas J; Stratton E; Keppens M Expert Rev Mol Diagn; 2012 Jul; 12(6):561-3. PubMed ID: 22845476 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics and diagnostics. Persidis A Nat Biotechnol; 1998 Aug; 16(8):791-2. PubMed ID: 9702782 [No Abstract] [Full Text] [Related]
11. Theranos phenomenon - Part 5: Theranos' presentation at the American Association for Clinical Chemistry Annual Conference 2016. Diamandis EP; Plebani M Clin Chem Lab Med; 2016 Oct; 54(10):e313-4. PubMed ID: 27574855 [No Abstract] [Full Text] [Related]
12. The meteoric rise and dramatic fall of Theranos: lessons learned for the diagnostic industry. Fiala C; Diamandis EP Clin Chem Lab Med; 2018 Aug; 56(9):1443-1446. PubMed ID: 29750644 [TBL] [Abstract][Full Text] [Related]
13. Theranos phenomenon - part 2. Li M; Diamandis EP Clin Chem Lab Med; 2015 Nov; 53(12):1911-2. PubMed ID: 26402887 [TBL] [Abstract][Full Text] [Related]
14. Drugs and diagnostic innovations to improve global health. Peeling RW; Nwaka S Infect Dis Clin North Am; 2011 Sep; 25(3):693-705, xi. PubMed ID: 21896368 [TBL] [Abstract][Full Text] [Related]
15. Evaluating and using innovative technologies: a lesson from Theranos? Plebani M Clin Chem Lab Med; 2015 Jun; 53(7):961-2. PubMed ID: 25996487 [No Abstract] [Full Text] [Related]
16. Theranos phenomenon--part 3. Li M; Diamandis EP Clin Chem Lab Med; 2016 May; 54(5):e145-6. PubMed ID: 26966932 [No Abstract] [Full Text] [Related]
17. Innovations in diagnostic methods for sexually transmitted infections. Ward H; Miller RF Sex Transm Infect; 2006 Dec; 82(6):423-4. PubMed ID: 17151026 [No Abstract] [Full Text] [Related]
18. A change of gear at Siemens. Schiermeier Q Nature; 2007 Aug; 448(7156):852-3. PubMed ID: 17713499 [No Abstract] [Full Text] [Related]
19. The Theranos phenomenon, scientific transparency and freedom of speech. Lackner KJ; Gillery P; Lippi G; Melichar B; Schlattmann P; Tate JR; Plebani M Clin Chem Lab Med; 2016 Sep; 54(9):1403-5. PubMed ID: 27442369 [No Abstract] [Full Text] [Related]
20. The promise of disease proteomics: faster detection, diagnosis, and drug development. Wilson JF Ann Intern Med; 2004 Feb; 140(4):317-9. PubMed ID: 14970168 [No Abstract] [Full Text] [Related] [Next] [New Search]